Delicia Honen Yard

Consistent users of the Internet were more likely than never-users to engage in cancer-preventive behaviors, a large study revealed.

A combination of blood proteins was able to differentiate between benign lung nodules and early-stage lung cancer with 90% probability, thereby providing a diagnostic tool to avoid invasive biopsy on benign nodules.

Bladder cancer characterized by mutations of the STAG2 gene appears to be less likely to recur than bladder cancer with no such mutations, researchers have discovered.

Thyroid cancer discovered during imaging that is being performed for reasons other than evaluation of that gland is often similar to nonincidentally discovered thyroid cancer in terms of tumor size, pathology, and behavior.

The findings of two recent studies illuminate the cancer-fighting properties of resveratrol, a phytochemical found in red wine.

Higher tumor uptake of a radiotracer used in positron emission tomography (PET) appears to be a predictor of worse survival in persons who have undergone treatment for stage III non-small cell lung cancer.

Persons with differentiated thyroid carcinoma are at heightened risks for cardiovascular and all-cause mortality independent of age, sex, and cardiovascular risk factors, researchers have learned.

All persons with invasive breast cancer (early stage or recurrence) should undergo testing for human epidermal growth factor receptor 2 (HER2), and at least one tumor sample should be tested for either HER2 protein expression or HER2 gene amplification.

Sentinel lymph node surgery was associated with a false-negative rate higher than a prespecified threshold in women who underwent chemotherapy after initially presenting with biopsy-proven breast cancer in movable axillary lymph nodes.

A newly discovered biomarker for pancreatic cancer could provide a new avenue of treatment for the disease.